MedTrace Logo

Acceptability and Tolerance Study of a New Oral Nutritional Supplement (ONS)

NCT02898038 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2016-09-13

No results posted yet for this study

Summary

Tolerance and Acceptability of new oral nutritional supplement - AYMES PARIS

Conditions

  • Malnutrition

Interventions

DIETARY_SUPPLEMENT

AYMES PARIS

AYMES PARIS is a powdered, high energy, oral nutritional supplement to be mixed with milk as a drink. It provides 320 kcal and 12.2 g protein per 139 ml serving. It is a Food for Special Medical Purposes (FSMP) and must, therefore, be used under medical supervision. It is not designed as a sole source of nutrition.

Sponsors & Collaborators

  • Alison Clark Health and Nutrition

    collaborator OTHER

  • Aymes International Limited

    lead INDUSTRY

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2015-11-30
Completion
2015-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02898038 on ClinicalTrials.gov